XML 29 R11.htm IDEA: XBRL DOCUMENT v2.3.0.15
Share-Based Compensation
9 Months Ended
Oct. 01, 2011
Share-Based Compensation [Abstract] 
Share-Based Compensation

NOTE F – SHARE-BASED COMPENSATION

Share-based compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, typically the vesting period. The vesting period for the share-based compensation awarded by the Company is generally three years. The Company uses the Black-Scholes option pricing model to determine the fair value of stock option grants. The Company uses the closing market price of its common stock on the date of grant to determine the fair value of restricted stock and restricted stock units.

The Company used the following assumptions for the Black-Scholes option-pricing model to determine the fair value of options granted during the nine months ended October 1, 2011 and October 2, 2010:

 

     For the Nine Months Ended  
     October 1, 2011      October 2, 2010  

Risk-free interest rate

     0.66% and 1.83%         1.85% and 2.14%   

Expected dividend yield

     0%         0%   

Expected option life

     4 years         4 years   

Expected volatility

     47.9% - 48.7%         43.5% and 46.5%   

Weighted-average expected volatility

     48.7%         46.5%   

Historical information was the primary basis for the selection of the expected dividend yield, expected volatility and the expected lives of the options. The risk-free interest rate was based on yields of U.S. zero coupon issues and U.S. Treasury issues, with a term equal to the expected life of the option being valued.

The Company recorded total share-based compensation expense of $676 and $596 for the three months ended October 1, 2011 and October 2, 2010, respectively, and $2,070 and $1,819 for the nine months ended October 1, 2011 and October 2, 2010, respectively.

A summary of stock option activity and weighted average exercise prices for the nine months ended October 1, 2011 follows:

 

     Options     Weighted-Average
Exercise Price
     Weighted-Average
Remaining
Contractual Term
     Aggregate Intrinsic
Value as of
October 1, 2011
 

Outstanding at January 1, 2011

     1,098,859      $ 21.37         

Granted

     271,412        35.89         

Forfeited

     (26,993     28.21         

Exercised

     (397,498     19.47         
  

 

 

   

 

 

    

 

 

    

 

 

 

Outstanding at October 1, 2011

     945,780      $ 26.13         4.8       $ 6,273   
  

 

 

   

 

 

    

 

 

    

 

 

 

Options exercisable at October 1, 2011

     493,973      $ 22.94         3.9       $ 4,255   
  

 

 

   

 

 

    

 

 

    

 

 

 

 

The weighted-average grant-date fair value of the stock options granted during the nine months ended October 1, 2011 and October 2, 2010 was $14.15 and $9.30 per option, respectively. The total intrinsic value of stock options exercised during the three months ended October 1, 2011 and October 2, 2010 was $1.4 million and $0.0 million, respectively. The total intrinsic value of stock options exercised during the nine months ended October 1, 2011 and October 2, 2010 was $8.4 million and $0.2 million, respectively. The total fair value of stock options vested during the three months ended October 1, 2011 and October 2, 2010 was $0.0 million and $0.0 million, respectively. The total fair value of stock options vested during the nine months ended October 1, 2011 and October 2, 2010 was $1.6 million and $1.7 million, respectively.

The following table summarizes the restricted stock and restricted stock unit activity and weighted average grant-date fair values for the nine months ended October 1, 2011:

 

     Shares     Weighted-Average
Grant Date
Fair Value
 

Non-vested at beginning of period

     40,313      $ 23.53   

Granted

     18,117        38.97   

Forfeited

     (624     18.96   

Vested

     (28,207     26.10   
  

 

 

   

 

 

 

Non-vested at October 1, 2011

     29,599      $ 30.62   
  

 

 

   

 

 

 

As of October 1, 2011, there was $4.5 million of total unrecognized stock-based compensation expense related to non-vested stock-based compensation arrangements. The expense is expected to be recognized over a weighted average period of 2.4 years.